Loading...
Please wait, while we are loading the content...
Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review.
| Content Provider | Europe PMC |
|---|---|
| Author | Suero-Abreu, Giselle Alexandra Zanni, Markella V. Neilan, Tomas G. |
| Copyright Year | 2022 |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC9830225&blobtype=pdf |
| Journal | JACC: CardioOncology [JACC CardioOncol] |
| Volume Number | 4 |
| DOI | 10.1016/j.jaccao.2022.11.011 |
| PubMed Central reference number | PMC9830225 |
| Issue Number | 5 |
| PubMed reference number | 36636438 |
| e-ISSN | 26660873 |
| Language | English |
| Publisher | Elsevier |
| Publisher Date | 2022-12-20 |
| Access Restriction | Open |
| Rights License | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). © 2022 The Authors |
| Subject Keyword | atherosclerosis cardio-oncology cardiovascular disease immune checkpoint inhibitor inflammation ASCVD, atherosclerotic cardiovascular disease CTLA-4, cytotoxic T-lymphocyte associated protein 4 ICI, immune checkpoint inhibitor IFN, interferon IL, interleukin irAE, immune-related adverse event PD-1, programmed cell death protein 1 PD-L1, programmed cell death ligand 1 TNF, tumor necrosis |
| Content Type | Text |
| Resource Type | Article |
| Subject | Oncology Cardiology and Cardiovascular Medicine |